Vetnio

Name: Vetnio
Brand: Vetnio (YC W25)

AI Native

The GDPR-compliant copilot for veterinary professionals.

Est 2024|Raised $1.5M

LinkedIn 2K|Web traffic 4K|FTEs 16|HQ Stockholm, 01, SE

01Competitive Landscape

Narrative analysis (where alternatives excel)

- Pricing transparency: Some competitors publish clearer public pricing and free plans, which can reduce procurement friction compared to partner- or demo-led pricing approaches. - Reviewability: Competitors with visible public reviews reduce information asymmetry for buyers; Vetnio currently has a limited public review footprint. - Integration approach: Vetnio’s browser-extension approach and claimed PIMS breadth may be advantageous where direct API integration is not available, but buyers should verify the practical reliability of extension-based workflows.

Market adoption signals

Signals of early adoption: accelerator participation and European investor interest indicate momentum; extension user counts suggest early adoption but not mass-market scale.

	Vetnio	Scribenote	PawfectNotes
Starting Price	Not clearly public; partner-channel per-account pricing reported via partner channels	Published per-seat pricing available on the vendor pricing page; historical references to higher published pricing appear in help center articles	Free tier available; paid pricing is sales-led and requires contact for clinic-scale subscriptions
Best For	EU/UK clinics or chains requiring GDPR-compliant hosting and PIMS workflows; teams already using supported PIMS	Clinics seeking transparent published per-seat pricing and a free option for evaluation	Clinics that benefit from a free tier and are willing to engage sales for scaled rollout
Key Strength	Multi-PIMS workflow via browser extension; EU data hosting claimed; accelerator participation and early enterprise pilot signals	Public pricing, free plan, and emphasis on scribing workflow	Free note allotments and clinic-oriented positioning
Key Weakness	Limited public reviews and security certifications not publicly documented; global pricing is not transparent	Pricing and plan presentation has changed historically and requires validation for current accuracy	Pricing transparency is limited and details depend on the sales process

01Competitive Landscape

Narrative analysis (where alternatives excel)

Pricing transparency: Some competitors publish clearer public pricing and free plans, which can reduce procurement friction compared to partner- or demo-led pricing approaches.
Reviewability: Competitors with visible public reviews reduce information asymmetry for buyers; Vetnio currently has a limited public review footprint.
Integration approach: Vetnio’s browser-extension approach and claimed PIMS breadth may be advantageous where direct API integration is not available, but buyers should verify the practical reliability of extension-based workflows.

Market adoption signals

Signals of early adoption: accelerator participation and European investor interest indicate momentum; extension user counts suggest early adoption but not mass-market scale.

	Vetnio	Scribenote	PawfectNotes
Starting Price	Not clearly public; partner-channel per-account pricing reported via partner channels	Published per-seat pricing available on the vendor pricing page; historical references to higher published pricing appear in help center articles	Free tier available; paid pricing is sales-led and requires contact for clinic-scale subscriptions
Best For	EU/UK clinics or chains requiring GDPR-compliant hosting and PIMS workflows; teams already using supported PIMS	Clinics seeking transparent published per-seat pricing and a free option for evaluation	Clinics that benefit from a free tier and are willing to engage sales for scaled rollout
Key Strength	Multi-PIMS workflow via browser extension; EU data hosting claimed; accelerator participation and early enterprise pilot signals	Public pricing, free plan, and emphasis on scribing workflow	Free note allotments and clinic-oriented positioning
Key Weakness	Limited public reviews and security certifications not publicly documented; global pricing is not transparent	Pricing and plan presentation has changed historically and requires validation for current accuracy	Pricing transparency is limited and details depend on the sales process

Vetnio

01Competitive Landscape

Narrative analysis (where alternatives excel)

Market adoption signals

02Market Map

01Competitive Landscape

Narrative analysis (where alternatives excel)

Market adoption signals

02Market Map